vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and QUALYS, INC. (QLYS). Click either name above to swap in a different company.
QUALYS, INC. is the larger business by last-quarter revenue ($175.3M vs $123.8M, roughly 1.4× NATURES SUNSHINE PRODUCTS INC). QUALYS, INC. runs the higher net margin — 30.3% vs 3.3%, a 27.0% gap on every dollar of revenue. On growth, QUALYS, INC. posted the faster year-over-year revenue change (10.1% vs 4.7%). QUALYS, INC. produced more free cash flow last quarter ($74.9M vs $7.6M). Over the past eight quarters, QUALYS, INC.'s revenue compounded faster (9.6% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Qualys, Inc. is an American technology firm based in Foster City, California, specializing in cloud security, compliance and related services.
NATR vs QLYS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $175.3M |
| Net Profit | $4.1M | $53.1M |
| Gross Margin | 72.5% | 83.4% |
| Operating Margin | 4.3% | 33.6% |
| Net Margin | 3.3% | 30.3% |
| Revenue YoY | 4.7% | 10.1% |
| Net Profit YoY | 1379.4% | 20.9% |
| EPS (diluted) | $0.23 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $175.3M | ||
| Q3 25 | $128.3M | $169.9M | ||
| Q2 25 | $114.8M | $164.1M | ||
| Q1 25 | $113.2M | $159.9M | ||
| Q4 24 | $118.2M | $159.2M | ||
| Q3 24 | $114.6M | $153.9M | ||
| Q2 24 | $110.6M | $148.7M | ||
| Q1 24 | $111.0M | $145.8M |
| Q4 25 | $4.1M | $53.1M | ||
| Q3 25 | $5.3M | $50.3M | ||
| Q2 25 | $5.3M | $47.3M | ||
| Q1 25 | $4.7M | $47.5M | ||
| Q4 24 | $-321.0K | $44.0M | ||
| Q3 24 | $4.3M | $46.2M | ||
| Q2 24 | $1.3M | $43.8M | ||
| Q1 24 | $2.3M | $39.7M |
| Q4 25 | 72.5% | 83.4% | ||
| Q3 25 | 73.3% | 83.6% | ||
| Q2 25 | 71.7% | 82.4% | ||
| Q1 25 | 72.1% | 81.9% | ||
| Q4 24 | 72.0% | 81.8% | ||
| Q3 24 | 71.3% | 81.3% | ||
| Q2 24 | 71.4% | 82.2% | ||
| Q1 24 | 71.2% | 81.3% |
| Q4 25 | 4.3% | 33.6% | ||
| Q3 25 | 7.0% | 35.3% | ||
| Q2 25 | 3.7% | 31.3% | ||
| Q1 25 | 5.4% | 32.4% | ||
| Q4 24 | 3.8% | 31.0% | ||
| Q3 24 | 4.6% | 29.2% | ||
| Q2 24 | 5.1% | 32.3% | ||
| Q1 24 | 4.2% | 30.7% |
| Q4 25 | 3.3% | 30.3% | ||
| Q3 25 | 4.2% | 29.6% | ||
| Q2 25 | 4.6% | 28.8% | ||
| Q1 25 | 4.2% | 29.7% | ||
| Q4 24 | -0.3% | 27.6% | ||
| Q3 24 | 3.8% | 30.0% | ||
| Q2 24 | 1.2% | 29.4% | ||
| Q1 24 | 2.1% | 27.2% |
| Q4 25 | $0.23 | $1.47 | ||
| Q3 25 | $0.30 | $1.39 | ||
| Q2 25 | $0.28 | $1.29 | ||
| Q1 25 | $0.25 | $1.29 | ||
| Q4 24 | $-0.02 | $1.19 | ||
| Q3 24 | $0.23 | $1.24 | ||
| Q2 24 | $0.07 | $1.17 | ||
| Q1 24 | $0.12 | $1.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $250.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $561.2M |
| Total Assets | $261.1M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $250.3M | ||
| Q3 25 | $95.6M | $225.3M | ||
| Q2 25 | $81.3M | $194.0M | ||
| Q1 25 | $86.5M | $290.7M | ||
| Q4 24 | $84.7M | $232.2M | ||
| Q3 24 | $78.7M | $235.4M | ||
| Q2 24 | $68.7M | $281.2M | ||
| Q1 24 | $77.8M | $273.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $561.2M | ||
| Q3 25 | $166.7M | $529.4M | ||
| Q2 25 | $163.7M | $508.2M | ||
| Q1 25 | $167.1M | $498.0M | ||
| Q4 24 | $161.0M | $477.1M | ||
| Q3 24 | $162.6M | $449.6M | ||
| Q2 24 | $156.4M | $427.8M | ||
| Q1 24 | $159.7M | $404.2M |
| Q4 25 | $261.1M | $1.1B | ||
| Q3 25 | $264.8M | $1.0B | ||
| Q2 25 | $254.9M | $999.5M | ||
| Q1 25 | $252.7M | $996.5M | ||
| Q4 24 | $240.9M | $973.5M | ||
| Q3 24 | $245.3M | $908.3M | ||
| Q2 24 | $235.8M | $876.6M | ||
| Q1 24 | $247.3M | $861.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $75.7M |
| Free Cash FlowOCF − Capex | $7.6M | $74.9M |
| FCF MarginFCF / Revenue | 6.1% | 42.8% |
| Capex IntensityCapex / Revenue | 1.9% | 0.4% |
| Cash ConversionOCF / Net Profit | 2.41× | 1.42× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $304.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $75.7M | ||
| Q3 25 | $18.5M | $90.4M | ||
| Q2 25 | $4.3M | $33.8M | ||
| Q1 25 | $2.6M | $109.6M | ||
| Q4 24 | $12.2M | $47.7M | ||
| Q3 24 | $9.6M | $61.0M | ||
| Q2 24 | $1.3M | $49.8M | ||
| Q1 24 | $2.2M | $85.5M |
| Q4 25 | $7.6M | $74.9M | ||
| Q3 25 | $16.8M | $89.5M | ||
| Q2 25 | $3.0M | $32.4M | ||
| Q1 25 | $1.5M | $107.5M | ||
| Q4 24 | $10.0M | $41.9M | ||
| Q3 24 | $7.9M | $57.6M | ||
| Q2 24 | $-2.0M | $48.8M | ||
| Q1 24 | $-1.5M | $83.5M |
| Q4 25 | 6.1% | 42.8% | ||
| Q3 25 | 13.1% | 52.7% | ||
| Q2 25 | 2.6% | 19.8% | ||
| Q1 25 | 1.3% | 67.3% | ||
| Q4 24 | 8.5% | 26.3% | ||
| Q3 24 | 6.9% | 37.4% | ||
| Q2 24 | -1.9% | 32.8% | ||
| Q1 24 | -1.4% | 57.2% |
| Q4 25 | 1.9% | 0.4% | ||
| Q3 25 | 1.3% | 0.5% | ||
| Q2 25 | 1.2% | 0.8% | ||
| Q1 25 | 1.0% | 1.3% | ||
| Q4 24 | 1.9% | 3.7% | ||
| Q3 24 | 1.5% | 2.2% | ||
| Q2 24 | 3.0% | 0.7% | ||
| Q1 24 | 3.3% | 1.4% |
| Q4 25 | 2.41× | 1.42× | ||
| Q3 25 | 3.46× | 1.80× | ||
| Q2 25 | 0.81× | 0.71× | ||
| Q1 25 | 0.55× | 2.31× | ||
| Q4 24 | — | 1.09× | ||
| Q3 24 | 2.21× | 1.32× | ||
| Q2 24 | 0.97× | 1.14× | ||
| Q1 24 | 0.94× | 2.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
QLYS
| Sales Channel Through Intermediary | $88.6M | 51% |
| Sales Channel Directly To Consumer | $86.7M | 49% |
